In an interview, James D. Chambers, Ph.D., from Tufts Medical Center, talks about the factors that are impacting the ...

In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...

TOPLINE: In adults with psoriasis, adding methotrexate to adalimumab did not improve effectiveness or drug survival compared with adalimumab alone, according to a UK cohort study of patients with ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial ...

CLERMONT-FERRAND, France—Michelin will invest over $60 million to construct an initial industrial demonstration unit for a bio-sourced, non-toxic molecule, known as a "sleeping giant." 5-HMF, also ...

See full indications below. Patients treated with adalimumab products, including HADLIMA, are at increased risk for developing serious infections that may lead to hospitalization or death.

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small ...

Their research, published in Alzheimer's & Dementia, reveals that an immune molecule called STING drives the formation of the harmful plaques and protein tangles thought responsible for Alzheimer's.